Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?

Acute Cardiac Care

Volumn 11, Issue 4, 2009, Pages 236-242

  Timóteo, Ana Teresa ^a   Toste, Alexandra ^a   Ramos, Ruben ^a   Miranda, Fernando ^a   Ferreira, Maria Lurdes ^a   Oliveira, José Alberto ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Acute coronary syndromes; Admission N terminal proBNP; GRACE risk score; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; GRACE RISK SCORE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM;

ACUTE CORONARY SYNDROME; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PATIENT ADMISSION; PEPTIDE FRAGMENTS; PORTUGAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 72049108379     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940903177036     Document Type: Article

References (23)

1. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825-832
2. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Eng J Med. 2002;347:161-167
3. Poole-Wilson PA. Who are the enemies? Lack of oxygen. Eur Heart J. 2002;4(Suppl.G):15-19
4. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993;88:82-91. (Pubitemid 23195436)
5. Kwan G, Isaksom SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. J Am Coll Cardiol. 2007;49:1186-1192
6. Singh M, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger VL. Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106:2309-2314
7. Granger CB, Goldberg RJ, Dabbous O, Pieper KJ, Eagle KA, Cannon CP, et al. Predictors of hospital mortality with global registry of acute coronary events. Arch Intern Med. 2003;163:2345-2353
8. Cockcroft DW, Gault MH. Predictors of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
9. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactiveamino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol. 1997;47:287-296
10. van Kimmenade RJ, Januzzi JL, Bakker JA, et al. Renal clearance of B type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: a mechanism study of hypertensive subjects. J Am Coll Cardiol. 2009;53:884-890
11. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest. 1994;72:30-34
12. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP investigation of dyspnea in the emergency department (PRIDE) substudy. Am Heart J. 2005;149:744-750
13. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggiani AP, et al. N-terminal Pro-Brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation. 2004;110:128-134
14. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J. 2005;26:234-240
15. Bazzino O, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2004;25:859-866
16. Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolerz P, et al. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated by primary angioplasty. Int J Cardiol. 2007;115:386-390
17. Jarai R, Iordanova N, Jarai R, et al. Prediction of clinical outcome in patients with non-ST-segment elevation acute coronary syndrome using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels. Wien Klin Wochenschr. 2007;119/21-22:626-632
18. Khan SQ, Quinn P, Davies JE, Ng LL. N-terminal pro-Btype natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Heart. 2008;94:40-43
19. James SK, Lindahl B, Timmer JR, Ottervanger JP, Siegbahn A, Stridsberg M, et al. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). Am J Cardiol. 2006;97:167-172
20. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PN, Morrow DA, et al. Association of elevated B-type natriuretic peptide levels with angina and non-STsegment elevation myocardial infarction. J Am Coll Cardiol. 2004;44:564-568
21. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmit- Schweda S, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin 2 and diastolic fiber length. Circulation. 2000;102:3074-3079
22. Goetze JP, Christofferson C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J. 2003;17: 1105-1110
23. Heeschen C, Hamm CW, Mitrovic V, Lantelme N, White HD. N-terminal Pro-B-type natriuretic peptide levels for dynamic risk stratification in patients with acute coronary syndromes. Circulation. 2004;110:3206-3212